This is a working overview of freeze-thaw cycle, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
{\displaystyle \mu ={\frac {1}{j+1}}{\Bigl \langle }(l,s),j,m_{j}{=}j\,{\Bigr |}\left({\frac {1}{2}}{\vec {l}}{g^{(l)}}_{p}+{\frac {1}{2}}{\vec {s}}({g^{(s)}}_{p}+{g^{(s)}}_{n})\right)\cdot {\vec {\jmath }}\,{\Bigl |}\,(l,s),j,m_{j}{=}j{\Bigr \rangle }}
== Pharmacokinetics == The major source of retinoids in the human diet is plant pigments such as carotenes and retinyl esters derived from animal sources. Retinyl esters are transported through the chylomicron pathway to the liver or fat tissue while retinol or carotenes are transported from the enterocytes to the liver and are processed into retinyl esters by LRAT for storage. Most synthetic retinoids are absorbed when taken orally, while topical retinoids cannot diffuse through the skin barrier unless it is compromised. All classes of retinoid bind to many proteins. Natural retinoids such as retinol and retinyl esters bind to carrier proteins such as RBP4, chylomicrons and VLDL while synthetic retinoids likely bind to these and other proteins. First generation retinoids are rapidly metabolized by Cytochrome p450 enzymes, typically of the Cyp26 family.
The pituitary gland hangs from the base of the brain by the pituitary stalk, and is enclosed by bone. It consists of a hormone-producing glandular portion of the anterior pituitary and a neural portion of the posterior pituitary, which is an extension of the hypothalamus. The hypothalamus regulates the hormonal output of the anterior pituitary and creates two hormones that it exports to the posterior pituitary for storage and later release. Four of the six anterior pituitary hormones are tropic hormones that regulate the function of other endocrine organs. Most anterior pituitary hormones exhibit a diurnal rhythm of release, which is subject to modification by stimuli influencing the hypothalamus. Somatotropic hormone or growth hormone (GH) is an anabolic hormone that stimulates the growth of all body tissues especially skeletal muscle and bone. It may act directly, or indirectly via insulin-like growth factors (IGFs). GH mobilizes fats, stimulates protein synthesis, and inhibits glucose uptake and metabolism. Secretion is regulated by growth hormone-releasing hormone (GHRH) and growth hormone-inhibiting hormone (GHIH), or somatostatin. Hypersecretion causes gigantism in children and acromegaly in adults; hyposecretion in children causes pituitary dwarfism. Thyroid-stimulating hormone promotes normal development and activity of the thyroid gland. Thyrotropin-releasing hormone stimulates its release; negative feedback of thyroid hormone inhibits it. Adrenocorticotropic hormone stimulates the adrenal cortex to release corticosteroids.
Dirt received critical acclaim, and is considered by many critics and fans alike as the group's magnum opus. In a retrospective review, Steve Huey of AllMusic said "Dirt is Alice in Chains' major artistic statement and the closest they ever came to recording a flat-out masterpiece. It's a primal, sickening howl from the depths of Layne Staley's heroin addiction, and one of the most harrowing concept albums ever recorded. Not every song on Dirt is explicitly about heroin, but Jerry Cantrell's solo-written contributions (nearly half the album) effectively maintain the thematic coherence—nearly every song is imbued with the morbidity, self-disgust, and/or resignation of a self-aware yet powerless addict." Michael Christopher of PopMatters praised the album, stating, "The record wasn't celebratory by any means—but you'll be hard-pressed to find a more brutally truthful work laid down—and that's why it will always be one of the greatest records ever made." Chris Gill of Guitar World described Dirt as "huge and foreboding, yet eerie and intimate," as well as "sublimely dark and brutally honest." Don Kaye of Kerrang! described Dirt as "an unflinching, brutally truthful and, yes, fiercely rocking testimonial to human endurance." A writer for Pitchfork noted that the album made Alice in Chains "one of the most famous bands in the world." At the 1993 Grammy Awards, Dirt received a nomination for Best Hard Rock Performance.
Sources: en.wikipedia.org
Early researchers found that an electric or magnetic field could split radioactive emissions into three types of beams. Ernest Rutherford named the three types alpha, beta, and gamma, in increasing order of their ability to penetrate matter. Alpha decay is observed only in heavier elements of atomic number 52 (tellurium) and greater, with the exception of beryllium-8 (which decays to two alpha particles). Gamma rays are emitted from excited states of nuclei as a side effect of alpha or beta decay. Beta decay is the only type to be observed in all the elements. Lead, atomic number 82, is the heaviest element to have any isotopes stable (to the limit of measurement) to radioactive decay. Radioactive decay is seen in all isotopes of all elements of atomic number 83 (bismuth) or greater. Bismuth-209, however, is only very slightly radioactive, with a half-life greater than the age of the universe by ten orders of magnitude; radioisotopes with extremely long half-lives are considered effectively stable for practical purposes. In analyzing the nature of the decay products, it was obvious from the direction of the electromagnetic forces applied to the radiations by external magnetic and electric fields that alpha particles carried a positive charge, beta particles carried a negative charge, and gamma rays were neutral. From the magnitude of deflection, it was clear that alpha particles were much more massive than beta particles.
Ethylene oxide is one of the most important raw materials used in large-scale chemical production. Most ethylene oxide is used for synthesis of ethylene glycols, including diethylene glycol and triethylene glycol, that accounts for up to 75% of global consumption. Other important products include ethylene glycol ethers, ethanolamines, and ethoxylates. Among glycols, ethylene glycol is used as antifreeze, in the production of polyester and polyethylene terephthalate (PET – raw material for plastic bottles), liquid coolants, and solvents.
George Mikes, Hungarian-born comic writer Ralph Miliband (born Adolphe Miliband; 7 January 1924 – 21 May 1994) sociologist and Marxist author of Polish Jewish ancestry; father of Ed Miliband and David Miliband, described as "one of the best known academic Marxists of his generation", on a par with E. P. Thompson, Eric Hobsbawm and Perry Anderson. Beth Miller, novelist and nonfiction writer. Her first two novels were When We Were Sisters (Ebury, 2014) and The Good Neighbour (Ebury, 2015). The Two Hearts of Eliza Bloom (Bookouture, 2019), tells the story of Eliza, an Orthodox Jewish girl who runs away on the day of her arranged marriage; and The Missing Letters of Mrs Bright (Bookouture, 2020), Yvonne Mitchell (born Yvonne Frances Joseph; 7 July 1915) actress, playwright, biographer, novelist and author; acting roles include Julia in the 1954 BBC adaptation of George Orwell's novel Nineteen Eighty-Four; also an established author, writing several books for children and adults as well as winning awards for playwriting. Her plays include The Same Sky. She wrote an acclaimed biography of the French writer Colette, and her own autobiography was published in 1957.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.